Montegrande, Marjury .
HRN: 23-25-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2025
CO-AMOXICLAV 625MG (TAB)
04/23/2025
04/30/2025
ORAL
625mg
BID
S/P CS
Waiting Final Action
04/23/2025
MUPIROCIN 2%, 15G (TUBE)
04/23/2025
04/30/2025
SKIN
2%
BID
S/P CS
Waiting Final Action